[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Prekallikrein or KLKB1 or EC 3.4.21.34) - Drugs in Development, 2021

 US$ 3,000.00

Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Prekallikrein or KLKB1 or EC 3.4.21.34) - Drugs in Development, 2021 SUMMARY Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Pre...

April 2021 50 pages

Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development, 2021

 US$ 3,000.00

Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development, 2021 SUMMARY Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development, 2021 provides in depth analysis on Plasminogen (Pla...

April 2021 50 pages

Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) - Drugs in Development, 2021

 US$ 3,000.00

Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) - Drugs in Development, 2021 SUMMARY Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) - Drugs in Development, 2021 provides i...

April 2021 30 pages

Plasmodium falciparum Circumsporozoite Protein (CSP) - Drugs in Development, 2021

 US$ 3,000.00

Plasmodium falciparum Circumsporozoite Protein (CSP) - Drugs in Development, 2021 SUMMARY Plasmodium falciparum Circumsporozoite Protein (CSP) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 40 pages

Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) - Drugs in Development, 2021

 US$ 3,000.00

Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) - Drugs in Development, 2021 SUMMARY Plasmodium falciparum Merozoite Surface Protein 1 (Merozoit...

April 2021 30 pages

Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) - Drugs in Development, 2021 provides...

April 2021 70 pages

Platelet Glycoprotein VI (Glycoprotein 6 or Platelet Collagen Receptor or GPVI or GP6) - Drugs in Development, 2021

 US$ 3,000.00

Platelet Glycoprotein VI (Glycoprotein 6 or Platelet Collagen Receptor or GPVI or GP6) - Drugs in Development, 2021 SUMMARY Platelet Glycoprotein VI (Glycoprotein 6 or Platelet Collagen Receptor or GP...

April 2021 35 pages

Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Pleomorphic Liposarcoma pipeline lan...

April 2021 35 pages

Plexiform Neurofibroma (Non Malignant Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Plexiform Neurofibroma (Non Malignant Disorders) - Drugs in Development, 2021 SUMMARY Plexiform Neurofibroma (Non Malignant Disorders) - Drugs in Development, 2021 provides an overview of the Plexifor...

April 2021 30 pages

Pneumocystisosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Pneumocystisosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pneumocystisosis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pneumocystisosis pipeline land...

April 2021 35 pages

POEMS Syndrome (Crow-Fukase Syndrome) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

POEMS Syndrome (Crow-Fukase Syndrome) (Oncology) - Drugs in Development, 2021 SUMMARY POEMS Syndrome (Crow-Fukase Syndrome) (Oncology) - Drugs in Development, 2021 provides an overview of the POEMS Sy...

April 2021 35 pages

Pol Polyprotein - Drugs in Development, 2021

 US$ 3,000.00

Pol Polyprotein - Drugs in Development, 2021 SUMMARY Pol Polyprotein - Drugs in Development, 2021 provides in depth analysis on Pol Polyprotein targeted pipeline therapeutics. The report provides comp...

April 2021 40 pages

Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Dru...

April 2021 40 pages

Polycomb Protein EED (WD Protein Associating With Integrin Cytoplasmic Tails 1 or WAIT1 or EED) - Drugs in Development, 2021

 US$ 3,000.00

Polycomb Protein EED (WD Protein Associating With Integrin Cytoplasmic Tails 1 or WAIT1 or EED) - Drugs in Development, 2021 SUMMARY Polycomb Protein EED (WD Protein Associating With Integrin Cytoplas...

April 2021 30 pages

Polymerase Basic Protein 2 (RNA Directed RNA Polymerase Subunit P3 or PB2) - Drugs in Development, 2021

 US$ 3,000.00

Polymerase Basic Protein 2 (RNA Directed RNA Polymerase Subunit P3 or PB2) - Drugs in Development, 2021 SUMMARY Polymerase Basic Protein 2 (RNA Directed RNA Polymerase Subunit P3 or PB2) - Drugs in De...

April 2021 30 pages

Polymyositis (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Polymyositis (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Polymyositis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Polymyositis pipeline la...

April 2021 35 pages

Polyomavirus Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Polyomavirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Polyomavirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Polyomavirus Inf...

April 2021 50 pages

Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2021 SUMMARY Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2...

April 2021 80 pages

Post Operative Nausea And Vomiting (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Post Operative Nausea And Vomiting (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Post Operative Nausea And Vomiting (Gastrointestinal) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Post-Transplant Lymphoproliferative Disorder (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Post-Transplant Lymphoproliferative Disorder (Oncology) - Drugs in Development, 2021 SUMMARY Post-Transplant Lymphoproliferative Disorder (Oncology) - Drugs in Development, 2021 provides an overview o...

April 2021 35 pages

Posterior Uveitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Posterior Uveitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Posterior Uveitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Posterior Uveitis pipeline landscape....

April 2021 45 pages

Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Postherpet...

April 2021 50 pages

Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Postoperative Ileus pipeline...

April 2021 30 pages

Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) - Drugs in Development, 2021

 US$ 3,000.00

Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) - Drugs in Development, 2021 SUMMARY Potassium Transporting ATPase Alpha Cha...

April 2021 60 pages

Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Drugs in Development, 2021

 US$ 3,000.00

Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Drugs in Development, 2021 SUMMARY Potassium Voltage Gated Channel Subfamily A Member 3...

April 2021 40 pages

Potassium Voltage Gated Channel Subfamily H Member 2 (HERG or Voltage Gated Potassium Channel Subunit Kv11.1 or Eag Homolog or KCNH2) - Drugs in Development, 2021

 US$ 3,000.00

Potassium Voltage Gated Channel Subfamily H Member 2 (HERG or Voltage Gated Potassium Channel Subunit Kv11.1 or Eag Homolog or KCNH2) - Drugs in Development, 2021 SUMMARY Potassium Voltage Gated Chann...

April 2021 35 pages

Pouchitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Pouchitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Pouchitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Pouchitis pipeline landscape. The report provide...

April 2021 35 pages

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 SUMMARY Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pre-Eclampsia pipeline landscape. The report...

April 2021 35 pages

Premature Ovarian Failure (Women's Health) - Drugs in Development, 2021

 US$ 2,000.00

Premature Ovarian Failure (Women's Health) - Drugs in Development, 2021 SUMMARY Premature Ovarian Failure (Women's Health) - Drugs in Development, 2021 provides an overview of the Premature Ovarian Fa...

April 2021 30 pages

Primary Ciliary Dyskinesia (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Primary Ciliary Dyskinesia (Respiratory) - Drugs in Development, 2021 SUMMARY Primary Ciliary Dyskinesia (Respiratory) - Drugs in Development, 2021 provides an overview of the Primary Ciliary Dyskines...

April 2021 35 pages

Primary CNS Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Primary CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Primary CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Primary CNS Lymphoma pipeline landscape. T...

April 2021 50 pages

Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 provides...

April 2021 30 pages

Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development,...

April 2021 30 pages

Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Primary Medi...

April 2021 130 pages

Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Developmen...

April 2021 55 pages

Primitive Neuroectodermal Tumor (PNET) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Primitive Neuroectodermal Tumor (PNET) (Oncology) - Drugs in Development, 2021 SUMMARY Primitive Neuroectodermal Tumor (PNET) (Oncology) - Drugs in Development, 2021 provides an overview of the Primit...

April 2021 40 pages

Proctitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Proctitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Proctitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Proctitis pipeline landscape. The report provide...

April 2021 35 pages

Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) - Drugs in Development, 2021

 US$ 3,000.00

Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) - Drugs in Development, 2021 SUMMARY Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3...

April 2021 95 pages

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021

 US$ 3,500.00

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021 SUMMARY Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021 pr...

April 2021 300 pages

Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) - Drugs in Development, 2021

 US$ 3,000.00

Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) - Drugs in Development, 2021 SUMMARY Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) - Drugs in De...

April 2021 35 pages

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021

 US$ 3,500.00

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021 SUMMARY Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021 provides in depth anal...

April 2021 270 pages

Progressive Familial Intrahepatic Cholestasis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Progressive Familial Intrahepatic Cholestasis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Progressive Familial Intrahepatic Cholestasis (Gastrointestinal) - Drugs in Development, 2021 prov...

April 2021 35 pages

Prolow Density Lipoprotein Receptor Related Protein 1 (Alpha 2 Macroglobulin Receptor or Apolipoprotein E Receptor or CD91 or LRP1) - Drugs in Development, 2021

 US$ 3,000.00

Prolow Density Lipoprotein Receptor Related Protein 1 (Alpha 2 Macroglobulin Receptor or Apolipoprotein E Receptor or CD91 or LRP1) - Drugs in Development, 2021 SUMMARY Prolow Density Lipoprotein Rece...

April 2021 30 pages

Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) - Drugs in Development, 2021

 US$ 3,000.00

Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) - Drugs in Development, 2021 SUMMARY Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) - Drugs in...

April 2021 30 pages

Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Propionic Acidemia pipel...

April 2021 35 pages

Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) - Drugs in Development, 2021

 US$ 3,000.00

Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) - Drugs in Development, 2021 SUMMARY Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or...

April 2021 55 pages

Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1) - Drugs in Development, 2021

 US$ 3,000.00

Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1) - Drugs in Development, 2021 SUMMARY Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1) - Drugs in Deve...

April 2021 50 pages

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drugs in Development, 2021

 US$ 3,000.00

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drugs in Development, 2021 SUMMARY Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drugs in Deve...

April 2021 35 pages

Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) - Drugs in Development, 2021

 US$ 3,000.00

Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) - Drugs in Development, 2021 SUMMARY Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) - Drugs in Development, 2021 pr...

April 2021 60 pages

Prostaglandin G/H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) - Drugs in Development, 2021

 US$ 3,000.00

Prostaglandin G/H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) - Drugs in Development, 2021 SUMMARY Prostaglan...

April 2021 160 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1